Partner Content Partner Content The first patient to be injected with an RNA based anti-canc... RNA Therapeutics
News NHS braces for tough winter, saying budget falls short Cancer and A&E waiting times may not recover
News Future uncertain for Innate and BMS' troubled lirilumab Doubts over future of cancer immunotherapy
News Tesaro gets European approval on Zejula, set to challenge AZ Tesaro's PARP drug approved in wider ovarian cancer population
News Samsung Bioepis Herceptin biosimilar approved in EU Mylan and Biocon resolve biosimilar manufacturing issues
News Roche double trial success could expand use of two new drugs A double trial success from Roche sees it eyeing a combination therapy in lucrative first-line lung cancer, and wider use of its just-approved haemophilia drug, Hemlibra.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
